WENDY SELIG plans to step down as president and CEO of the Melanoma Research Alliance, posts she has held for the past five years, in order to establish a new consulting venture.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
